Related Experiment Video
Updated: Jan 13, 2026

09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
2.2K
Genetic instruments and drug prediction: will APOC3 silencing reduce cardiovascular end points?
1Robarts Research Institute and Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario N6A 5B7 Canada.
European Journal of Preventive Cardiology
|January 7, 2026
Abstract
No abstract available in PubMed .

